Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Graf

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Psychiatric Research|October 2, 2021
Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorderPetra Steinacker, Mhd Rami Al Shweiki, Patrick Oeckl, et al.
Frontiers in Psychology|October 18, 2018
Somatosensory Stimulus Intensity Encoding in Borderline Personality DisorderKathrin Malejko, Dominik Neff, Rebecca C Brown, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 25, 2022
The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): A systematic reviewMohamed Elsayed, Khaled T Dardeer, Nimrat Khehra, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Journal of Psychiatric Research|November 2, 2022
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disordersNerea Gómez de San José, Julie Goossens, Mhd Rami Al Shweiki, et al.
Molecular Psychiatry|October 15, 2024
Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysisAmin Saberi, Amir Ebneabbasi, Sama Rahimi, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysisAmin Saberi, Amir Ebneabbasi, Sama Rahimi, et al.
BMJ Mental Health|August 21, 2025
Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophreniaPetra Steinacker, Leonie Werner, Alexander Tarabuko, et al.
BMC Cancer|December 4, 2025
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-EElena Sperk, Claire Lemanski, Christian Neumaier, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Psychiatric Research|October 2, 2021
Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorderPetra Steinacker, Mhd Rami Al Shweiki, Patrick Oeckl, et al.
Frontiers in Psychology|October 18, 2018
Somatosensory Stimulus Intensity Encoding in Borderline Personality DisorderKathrin Malejko, Dominik Neff, Rebecca C Brown, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|November 25, 2022
The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): A systematic reviewMohamed Elsayed, Khaled T Dardeer, Nimrat Khehra, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Journal of Psychiatric Research|November 2, 2022
Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disordersNerea Gómez de San José, Julie Goossens, Mhd Rami Al Shweiki, et al.
Molecular Psychiatry|October 15, 2024
Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysisAmin Saberi, Amir Ebneabbasi, Sama Rahimi, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysisAmin Saberi, Amir Ebneabbasi, Sama Rahimi, et al.
BMJ Mental Health|August 21, 2025
Evidence for reduced synaptic protein SNAP-25 in cerebrospinal fluid in major depressive disorder and schizophreniaPetra Steinacker, Leonie Werner, Alexander Tarabuko, et al.
BMC Cancer|December 4, 2025
Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase II trial TARGIT-EElena Sperk, Claire Lemanski, Christian Neumaier, et al.
Pageof 5